IL135544A - Simulated multi-forms of dihydrochloride of acid 2 - [2 - [4 - [bite (-4 fluorophenyl) methyl] - 1 - piperazinyl] ethoxy] acetic acid - Google Patents

Simulated multi-forms of dihydrochloride of acid 2 - [2 - [4 - [bite (-4 fluorophenyl) methyl] - 1 - piperazinyl] ethoxy] acetic acid

Info

Publication number
IL135544A
IL135544A IL13554498A IL13554498A IL135544A IL 135544 A IL135544 A IL 135544A IL 13554498 A IL13554498 A IL 13554498A IL 13554498 A IL13554498 A IL 13554498A IL 135544 A IL135544 A IL 135544A
Authority
IL
Israel
Prior art keywords
fluorophenyl
bis
acid dihydrochloride
methyl
piperazinyl
Prior art date
Application number
IL13554498A
Other languages
English (en)
Hebrew (he)
Other versions
IL135544A0 (en
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of IL135544A0 publication Critical patent/IL135544A0/xx
Publication of IL135544A publication Critical patent/IL135544A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL13554498A 1997-11-26 1998-11-26 Simulated multi-forms of dihydrochloride of acid 2 - [2 - [4 - [bite (-4 fluorophenyl) methyl] - 1 - piperazinyl] ethoxy] acetic acid IL135544A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97870193A EP0919550A1 (en) 1997-11-26 1997-11-26 Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
PCT/BE1998/000184 WO1999028310A1 (en) 1997-11-26 1998-11-26 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride

Publications (2)

Publication Number Publication Date
IL135544A0 IL135544A0 (en) 2001-05-20
IL135544A true IL135544A (en) 2004-02-08

Family

ID=8231072

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13554498A IL135544A (en) 1997-11-26 1998-11-26 Simulated multi-forms of dihydrochloride of acid 2 - [2 - [4 - [bite (-4 fluorophenyl) methyl] - 1 - piperazinyl] ethoxy] acetic acid

Country Status (39)

Country Link
US (2) US6262057B1 (cs)
EP (2) EP0919550A1 (cs)
JP (2) JP3996348B2 (cs)
KR (1) KR100557711B1 (cs)
CN (1) CN100406448C (cs)
AR (1) AR017676A1 (cs)
AT (1) ATE203237T1 (cs)
AU (1) AU735819B2 (cs)
BG (1) BG64155B1 (cs)
BR (1) BR9815405A (cs)
CA (1) CA2310318C (cs)
CO (1) CO4980892A1 (cs)
CZ (1) CZ295972B6 (cs)
DE (1) DE69801163T2 (cs)
DK (1) DK1034171T3 (cs)
EG (1) EG23776A (cs)
ES (1) ES2161552T3 (cs)
GC (1) GC0000094A (cs)
GR (1) GR3036702T3 (cs)
HU (1) HUP0100343A3 (cs)
ID (1) ID24964A (cs)
IL (1) IL135544A (cs)
MA (1) MA26569A1 (cs)
MY (1) MY119653A (cs)
NO (1) NO314692B1 (cs)
NZ (1) NZ504461A (cs)
PE (1) PE134899A1 (cs)
PL (1) PL190871B1 (cs)
PT (1) PT1034171E (cs)
RS (1) RS49904B (cs)
RU (1) RU2182575C2 (cs)
SI (1) SI20325A (cs)
SK (1) SK283237B6 (cs)
TN (1) TNSN98214A1 (cs)
TR (1) TR200001505T2 (cs)
TW (1) TWI225053B (cs)
UA (1) UA54568C2 (cs)
WO (1) WO1999028310A1 (cs)
ZA (1) ZA9810780B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002047689A2 (en) * 2000-12-15 2002-06-20 Ucb, S.A. Use of cetirizine or efletirizine for preventing urticaria
US20040254375A1 (en) * 2001-07-26 2004-12-16 Ousmane Diouf Process for the preparation of 2-(2-(4-(bis(4-fluorophenyl)methyl)-piperazin-1-yl)ethoxy)acetic acid derivatives or corresponding salt forms thereof and intermediates therefor
EP2266533A3 (en) * 2002-06-25 2011-12-14 Acrux DDS Pty Ltd Transdermal delivery rate control using amorphous pharmaceutical compositions
US20050181032A1 (en) * 2002-06-25 2005-08-18 Acrux Dds Pty Ltd. Metastable pharmaceutical compositions
WO2004105760A1 (en) * 2003-05-28 2004-12-09 Ucb Farchim, S.A. Use of efletirizine for treating persistent allergic rhinitis
WO2006050909A1 (en) * 2004-11-10 2006-05-18 Ucb Farchim Sa Novel forms of efletirizine dihydrochloride, processes for making them and pharmaceutical compositions including them
WO2008155777A2 (en) * 2007-06-18 2008-12-24 Cadila Healthcare Limited Process for preparing efletrizine
KR101006760B1 (ko) * 2008-07-17 2011-01-11 주식회사 진영테크 모터 순간 정전 복원 장치

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH505116A (it) * 1966-11-21 1971-03-31 Crc Ricerca Chim Metodo per l'ottenimento di derivati della piperazina
SE409706B (sv) * 1976-05-21 1979-09-03 Astra Pharma Prod Forfarande for framstellning av n,n-dimetyl-3-(4-bromfenyl)-3-3(3-pyridyl)-allylamin dihydroklorid monohydrat
JPS57149282A (en) * 1981-02-06 1982-09-14 Ucb Sa 2-(4-(diphenylmethyl)-1-piperazinyl)acetic acid and their derivatives as medicine
DK154078C (da) 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
GB8827391D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
GB8827390D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-pipera-zinyl)ethoxy)-acetic acid & its dihydrochloride
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
US5625358A (en) * 1993-09-13 1997-04-29 Analog Devices, Inc. Digital phase-locked loop utilizing a high order sigma-delta modulator
BE1010095A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Procede de preparation de l'acide 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl] ethoxy]-acetique et de ses sels.
BE1010094A3 (fr) * 1996-04-10 1997-12-02 Ucb Sa Nouveaux [2-(1-piperazinyl)ethoxy] methyle substitues.

Also Published As

Publication number Publication date
SK5942000A3 (en) 2000-10-09
HUP0100343A2 (hu) 2001-07-30
BG64155B1 (bg) 2004-02-27
TWI225053B (en) 2004-12-11
CA2310318A1 (en) 1999-06-10
ZA9810780B (en) 1999-05-31
KR100557711B1 (ko) 2006-03-07
RS49904B (sr) 2008-08-07
GR3036702T3 (en) 2001-12-31
ES2161552T3 (es) 2001-12-01
EP1034171B1 (en) 2001-07-18
UA54568C2 (uk) 2003-03-17
TNSN98214A1 (fr) 2005-03-15
JP3996348B2 (ja) 2007-10-24
NO20002631D0 (no) 2000-05-23
JP2001524548A (ja) 2001-12-04
HUP0100343A3 (en) 2001-09-28
JP2007224042A (ja) 2007-09-06
PL190871B1 (pl) 2006-02-28
NO20002631L (no) 2000-05-23
AU1327799A (en) 1999-06-16
CZ20001787A3 (cs) 2000-09-13
YU31600A (sh) 2002-03-18
PT1034171E (pt) 2001-11-30
PE134899A1 (es) 2000-01-11
BR9815405A (pt) 2000-10-10
US20010021712A1 (en) 2001-09-13
IL135544A0 (en) 2001-05-20
MA26569A1 (fr) 2004-12-20
CO4980892A1 (es) 2000-11-27
WO1999028310A1 (en) 1999-06-10
CN100406448C (zh) 2008-07-30
NZ504461A (en) 2001-06-29
EP1034171A1 (en) 2000-09-13
DE69801163D1 (en) 2001-08-23
DK1034171T3 (da) 2001-11-05
TR200001505T2 (tr) 2000-09-21
MY119653A (en) 2005-06-30
DE69801163T2 (de) 2002-03-28
ID24964A (id) 2000-08-31
US6335331B2 (en) 2002-01-01
ATE203237T1 (de) 2001-08-15
CN1279676A (zh) 2001-01-10
SI20325A (sl) 2001-02-28
RU2182575C2 (ru) 2002-05-20
PL340724A1 (en) 2001-02-26
GC0000094A (en) 2005-06-29
SK283237B6 (sk) 2003-04-01
EP0919550A1 (en) 1999-06-02
CA2310318C (en) 2003-10-21
EG23776A (en) 2007-08-08
BG104424A (en) 2001-01-31
AR017676A1 (es) 2001-09-12
AU735819B2 (en) 2001-07-19
US6262057B1 (en) 2001-07-17
KR20010032420A (ko) 2001-04-16
NO314692B1 (no) 2003-05-05
CZ295972B6 (cs) 2005-12-14

Similar Documents

Publication Publication Date Title
RU2303598C2 (ru) Полиморфные формы гидрохлорида 1-[4-(5-цианоиндол-3-ил)бутил]-4-(2-карбамоилбензофуран-5-ил)пиперазина
PL188450B1 (pl) Pochodne 4-fenylopiperydyny, sposób wytwarzania pochodnych 4-fenylopiperydyny, zastosowanie pochodnej 4-fenylopiperydyny oraz środek farmaceutyczny
JP2008509953A (ja) ４−［［（７ｒ）−８−シクロペンチル−７−エチル−５，６，７，８−テトラヒドロ−５−メチル−４−６−オキソ−２−ピペリジニル］アミノ］−３−メトキシ−ｎ−（１−メチル−４−ピペリジニル）ベンズアミドの水和物及び多形、その製造方法、並びにその薬物としての使用
EP3022209B1 (en) Dolutegravir potassium salt
JP2007224042A (ja) ２−〔２−〔４−〔ビス（４−フルオロフェニル）メチル〕−１−ピペラジニル〕エトキシ〕酢酸ジヒドロクロリドの偽多形
US20090247542A1 (en) Syntheses and preparations of polymorphs of crystalline aripiprazole
EP3656767A1 (en) Beraprost-314d monohydrate crystals and methods for preparation thereof
HK1019749A (en) Pseudopolymorphic forms of 2-2-4-bis(4-fluorophenyl)methyl-1-piperazinyl-ethoxy acetic acid dihydrochloride
MXPA00004826A (en) Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride
JP2013500250A (ja) 結晶型ｉのロスバスタチン亜鉛塩
HK1091206A1 (en) Stable polymorph of bifeprunox mesilate
WO2010107329A2 (en) Aripiprazole salts
HK1091206B (en) Stable polymorph of bifeprunox mesilate

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees